Global Nuclear Medicine Radioisotopes Market

Global Nuclear Medicine Radioisotopes Market Research Report 2021

Global Nuclear Medicine Radioisotopes Market

Global Nuclear Medicine Radioisotopes Market Research Report 2021


The research report on ‘Nuclear Medicine Radioisotopes Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Nuclear Medicine Radioisotopes Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Nuclear Medicine Radioisotopes Market Overview:

Global Nuclear Medicine Radioisotopes Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Nuclear Medicine Radioisotopes involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Nuclear Medicine Radioisotopes Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Nuclear Medicine Radioisotopes market in 2020.

Global Nuclear Medicine Radioisotopes Market Segmentation

By Type, Nuclear Medicine Radioisotopes market has been segmented into:

Thallium-201 (Tl-201)

Iodine (I-123)

Fluorine-18

Rubidium-82 (Rb-82)

Others

By Application, Nuclear Medicine Radioisotopes market has been segmented into:

Tumor

Heart Disease

Lymphoma

Thyroid Gland

Others

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Nuclear Medicine Radioisotopes market are:

Agfa-Gevaert Group

Braco

Cardiarc

Cardinal Health

CMR Naviscan (Gamma Medica Inc.)

Curium

Digirad

GE Healthcare

Nordion (Canada)

NTP Radioisotopes SOC

Positron

Segami

Siemens Healthcare

1. Market Overview of Nuclear Medicine Radioisotopes

1.1 Nuclear Medicine Radioisotopes Market Overview

1.1.1 Nuclear Medicine Radioisotopes Product Scope

1.1.2 Market Status and Outlook

1.2 Nuclear Medicine Radioisotopes Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Nuclear Medicine Radioisotopes Historic Market Size by Regions (2015-2020)

1.4 Nuclear Medicine Radioisotopes Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Nuclear Medicine Radioisotopes Sales Market by Type (2015-2026)

2.1 Global Nuclear Medicine Radioisotopes Historic Market Size by Type (2015-2020)

2.2 Global Nuclear Medicine Radioisotopes Forecasted Market Size by Type (2021-2026)

2.3 Thallium-201 (Tl-201)

2.4 Iodine (I-123)

2.5 Fluorine-18

2.6 Rubidium-82 (Rb-82)

2.7 Others

3. Covid-19 Impact Nuclear Medicine Radioisotopes Sales Market by Application (2015-2026)

3.1 Global Nuclear Medicine Radioisotopes Historic Market Size by Application (2015-2020)

3.2 Global Nuclear Medicine Radioisotopes Forecasted Market Size by Application (2021-2026)

3.3 Tumor

3.4 Heart Disease

3.5 Lymphoma

3.6 Thyroid Gland

3.7 Others

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Nuclear Medicine Radioisotopes Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Nuclear Medicine Radioisotopes Business

5.1 Agfa-Gevaert Group

5.1.1 Agfa-Gevaert Group Company Profile

5.1.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Specification

5.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Braco

5.2.1 Braco Company Profile

5.2.2 Braco Nuclear Medicine Radioisotopes Product Specification

5.2.3 Braco Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Cardiarc

5.3.1 Cardiarc Company Profile

5.3.2 Cardiarc Nuclear Medicine Radioisotopes Product Specification

5.3.3 Cardiarc Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Cardinal Health

5.4.1 Cardinal Health Company Profile

5.4.2 Cardinal Health Nuclear Medicine Radioisotopes Product Specification

5.4.3 Cardinal Health Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 CMR Naviscan (Gamma Medica Inc.)

5.5.1 CMR Naviscan (Gamma Medica Inc.) Company Profile

5.5.2 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Specification

5.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Curium

5.6.1 Curium Company Profile

5.6.2 Curium Nuclear Medicine Radioisotopes Product Specification

5.6.3 Curium Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Digirad

5.7.1 Digirad Company Profile

5.7.2 Digirad Nuclear Medicine Radioisotopes Product Specification

5.7.3 Digirad Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 GE Healthcare

5.8.1 GE Healthcare Company Profile

5.8.2 GE Healthcare Nuclear Medicine Radioisotopes Product Specification

5.8.3 GE Healthcare Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Nordion (Canada)

5.9.1 Nordion (Canada) Company Profile

5.9.2 Nordion (Canada) Nuclear Medicine Radioisotopes Product Specification

5.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 NTP Radioisotopes SOC

5.10.1 NTP Radioisotopes SOC Company Profile

5.10.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Specification

5.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Positron

5.11.1 Positron Company Profile

5.11.2 Positron Nuclear Medicine Radioisotopes Product Specification

5.11.3 Positron Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 Segami

5.12.1 Segami Company Profile

5.12.2 Segami Nuclear Medicine Radioisotopes Product Specification

5.12.3 Segami Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Siemens Healthcare

5.13.1 Siemens Healthcare Company Profile

5.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Product Specification

5.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Nuclear Medicine Radioisotopes Market Size (2015-2026)

6.2 North America Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

6.3 North America Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

6.4 North America Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Nuclear Medicine Radioisotopes Market Size (2015-2026)

7.2 East Asia Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

7.3 East Asia Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

7.4 East Asia Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

8. Europe

8.1 Europe Nuclear Medicine Radioisotopes Market Size (2015-2026)

8.2 Europe Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

8.3 Europe Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

8.4 Europe Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Nuclear Medicine Radioisotopes Market Size (2015-2026)

9.2 South Asia Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

9.3 South Asia Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

9.4 South Asia Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Nuclear Medicine Radioisotopes Market Size (2015-2026)

10.2 Southeast Asia Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

10.3 Southeast Asia Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

10.4 Southeast Asia Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Nuclear Medicine Radioisotopes Market Size (2015-2026)

11.2 Middle East Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

11.3 Middle East Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

11.4 Middle East Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

12. Africa

12.1 Africa Nuclear Medicine Radioisotopes Market Size (2015-2026)

12.2 Africa Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

12.3 Africa Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

12.4 Africa Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Nuclear Medicine Radioisotopes Market Size (2015-2026)

13.2 Oceania Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

13.3 Oceania Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

13.4 Oceania Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

14. South America

14.1 South America Nuclear Medicine Radioisotopes Market Size (2015-2026)

14.2 South America Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

14.3 South America Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

14.4 South America Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Nuclear Medicine Radioisotopes Market Size (2015-2026)

15.2 Rest of the World Nuclear Medicine Radioisotopes Key Players in North America (2015-2020)

15.3 Rest of the World Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)

15.4 Rest of the World Nuclear Medicine Radioisotopes Market Size by Application (2015-2020)

16 Nuclear Medicine Radioisotopes Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Nuclear Medicine Radioisotopes Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Nuclear Medicine Radioisotopes Market?
Some of the finest and top-notch companies pioneering the Nuclear Medicine Radioisotopes Market are Agfa-Gevaert Group, Braco, Cardiarc, Cardinal Health, CMR Naviscan (Gamma Medica Inc.), Curium, Digirad, GE Healthcare, Nordion (Canada), NTP Radioisotopes SOC, Positron, Segami, Siemens Healthcare.
How is the competition changing gears in the Nuclear Medicine Radioisotopes Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as Agfa-Gevaert Group, Braco, Cardiarc, Cardinal Health, CMR Naviscan (Gamma Medica Inc.), Curium, Digirad, GE Healthcare, Nordion (Canada), NTP Radioisotopes SOC, Positron, Segami, Siemens Healthcare will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
Where are the Nuclear Medicine Radioisotopes used?
The Nuclear Medicine Radioisotopes are employed in Tumor, Heart Disease, Lymphoma, Thyroid Gland, Others.
What is the size of the Nuclear Medicine Radioisotopes Industry?
According to the report, the Nuclear Medicine Radioisotopes Industry will grow to USD XXX Million by 2030, with a YY% CAGR.
Is further segmentation possible given the scope of the Nuclear Medicine Radioisotopes Market study?
Yes, the add-on segmentation is available in the premium customised version of the Nuclear Medicine Radioisotopes Market report for a more in-depth analysis. It aids in the calculation of refined and precise market values.
How does the Nuclear Medicine Radioisotopes Market study reflects the current scenario?
The Nuclear Medicine Radioisotopes study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.